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Commentary
Humans are exposed to environmental 
chemicals through industrial and indoor air 
pollution, diet, and use of personal care and 
consumer products. Biomonitoring (i.e., mea-
surement of the environmental chemicals or 
their metabolites in biological speciments) is 
widely used to assess human internal exposure 
(i.e., body burden) to these chemicals [Centers 
for Disease Control and Prevention (CDC) 
2012; Den Hond et al. 2011; Frery et al. 
2012; Health Canada 2010; Kim et al. 2011; 
National Research Council 2006; Suzuki 
et al. 2010].
Proper biomonitoring practices take into 
account the selection of the relevant biomarker 
and biomonitoring matrix, the potential impact 
of the collection protocol on the biomarker 
levels in the sample, as well as the integrity 
of the sample during its collection, handling, 
storage, and analysis (Calafat and Needham 
2009). Furthermore, accurate and precise 
highly sensitive and selective multianalyte ana-
lytical methods for extraction, separation, and 
detection of the environmental chemicals are 
required to obtain valid biomonitoring data 
(Angerer et al. 2007). Participation in exter-
nal quality assessment programs [e.g., Arctic 
Monitoring and Assessment Program (Institut 
National de Santé Publique du Québec 2012), 
German External Quality Assessment Scheme 
(G-EQUAS; Social and Environmental 
Medicine of the University Erlangen-
Nuremberg 2012)] and the use of standard 
reference materials (SRMs) from the National 
Institute of Standards and Technology (Keller 
et al. 2010; Schantz et al. 2013) are very useful 
tools to evaluate method accuracy.
However, even with the application of 
sophisticated and accurate methods, external 
contamination with some ubiquitous environ-
mental organic chemicals, such as bisphenol A 
(BPA), polybrominated diphenyl ethers 
(PBDEs), and polychlorinated biphenyls 
(PCBs), during sample analysis can compro-
mise the analytical determination of these 
compounds [Alcock et al. 1994; Sjödin et al. 
2004; World Health Organization (WHO) 
2011]. External contamination can even pre-
clude accurate analyses of phthalate diesters, 
which are detected in the cleanest laboratory 
reagents, sampling equipment, and analytical 
apparatus. Therefore, assessing human expo-
sure to phthalates is routinely done by mea-
suring biomarkers that cannot be formed in 
the environment (e.g., oxidized metabolites 
of phthalates) instead of the phthalate diesters 
themselves (Koch and Calafat 2009).
Field blanks have been used to assess 
potential contamination during collection, 
processing, and/or transport of environmental 
samples (National Institute for Occupational 
Safety and Health 1994) and the importance 
of using field blanks in biomonitoring  studies 
has been presented (National Research Council 
2006; WHO 2011). Furthermore, it is well 
recognized that reagent or quality control 
blank (QCB) and quality control (QC) sam-
ples, when used and evaluated properly, are 
invaluable to monitoring potential contamina-
tion during analysis and the accuracy/ precision 
of the measurements (Taylor 1987).
Several reports have investigated potential 
sources of contamination with ubiquitous 
organic chemicals during sample analysis and 
how to mimimize contamination in a typical 
bio monitoring laboratory setup (Alcock et al. 
1994; Markham et al. 2010; Sjödin et al. 
2004; Xie et al. 2006). Here we present several 
case studies using the measurement of BPA 
and other ubiquitous environ mental organic 
chemicals (e.g., benzophenone-3, triclosan, 
parabens) in human urine, milk, and serum 
by on-line solid phase extraction coupled to 
isotope dilution–high performance liquid 
chromatography–tandem mass spectrometry 
(on-line SPE-HPLC-MS/MS) to discuss 
potential contamination scenarios during analy-
sis, including the reagents and apparatus used, 
the laboratory environment, and the analyst.
Discussion
Contamination from solvents and reagents. 
During analysis, contamination from solvents 
(including water) or reagents is monitored 
through the calculated concentration and the 
signal/noise (S/N) ratio of the reagent blank 
or QCB peak (Taylor 1987). However, the 
QCB calculated concentration per se might not 
reveal systematic contamination during analysis 
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(e.g., as when the same reagents/ solvents are 
used to prepare both QCB and standards). 
Concentrations of samples, including the QCB, 
are calculated from a calibration curve con-
structed by plotting the instrument response 
of analytical standards versus their known 
concentrations after automatically subtracting 
the y-intercept—the instrument response at 
a zero concentration—from the response of 
the samples (Taylor 1987). If the y-intercept 
includes a contribution from the contamina-
tion of reagents/solvents present in both the 
analytical standards and the QCB, the calcu-
lated concentration of the QCB will be around 
zero or below the limit of detection (LOD) 
of the method. Therefore, reagent or solvent 
contamination can not be revealed by the cal-
culated QCB concentration, but only through 
the higher than expected S/N ratio of the QCB 
(i.e., S/N > 3).
To measure BPA in urine, we have used 
methanol and water as mobile phases of an 
on-line SPE-HPLC-MS/MS system (Ye et al. 
2005, 2006). In one instance, right after the 
laboratory water purification system had been 
serviced during its regular preventative main-
tenance, we observed a high S/N ratio (19.6) 
of the BPA peak for the QCBs (Figure 1A). 
However, the calculated BPA concentration 
of the QCB was below the LOD, suggest-
ing that we had a systematic contamination. 
Further investigation confirmed that the con-
tamination was in the water and resulted from 
BPA leaching from a polyethersulfone filter 
installed during the preventative maintenance 
of the water purification system. After replac-
ing this filter with another brand of poly-
ethersulfone filter, the QCB S/N ratio went 
back to its normal levels (Figure 1B), suggest-
ing that the latter filter, albeit made from the 
same material as the first, did not leach BPA.
To minimize the impact of low-level con-
tamination of HPLC and SPE mobile phases 
with the target compounds (in this case, BPA), 
we modified our experimental configuration 
by adding guard cartridges to both mobile 
phase lines, similar to the approach we used 
before for filtering out an interference of 
perfluorooctanoate (Kuklenyik et al. 2009). 
Specifically, we added two C18 guard car-
tridges, one right after the SPE pump and 
another right after the HPLC pump 
(Figure 2). The SPE guard cartridge retains 
BPA during the loading of the sample on the 
SPE column with a relatively low organic con-
tent [e.g., 20% methanol in water (Ye et al. 
2005)], so the interference of BPA from the 
SPE mobile phase will not be loaded onto the 
SPE column. The BPA interference trapped 
in the SPE guard cartridge is flushed to waste 
during the SPE column regeneration step. 
When the BPA contaminant from the HPLC 
mobile phase retained on the HPLC guard 
cartridge elutes onto the HPLC analytical col-
umn with the HPLC gradient, the additional 
length of the guard cartridge delays the elu-
tion of the BPA contaminant compared with 
that of the “true” BPA peak from standards, 
QCs, and study samples. Figure 1C shows 
the extracted ion chromatograms of BPA 
from QCBs with BPA interference obtained 
when using contaminated water in both SPE 
and HPLC mobile phases, but adding guard 
cartridges after the SPE and HPLC pumps. 
Compared with Figure 1A, the BPA contami-
nation from the SPE solvent is completely 
removed. Noteworthy, the absence of another 
BPA peak at the expected longer retention 
time suggests that the BPA interference from 
the water in the HPLC mobile phase is negli-
gible compared with the BPA in the water of 
the SPE mobile phase, an interference that had 
been preconcentrated on the SPE cartridge.
When contamination affecting standards, 
QC materials, and study samples cannot be 
avoided completely, the concentration of 
study samples is adjusted by subtracting the 
contribution from the QCB. However, a high 
QCB contribution will increase the varia-
bility of measurements at low-concentration 
ranges. In the example above, contamination 
with BPA of the water purification system 
increased the frequency of out of control val-
ues of the low-concentration QC materials 
(~ 2.5 µg/L), which, unfortunately, is also 
around the median urinary concentration of 
BPA for the general population in various 
countries (CDC 2012; Health Canada 2010; 
Koch et al. 2012). Together, these findings 
show that careful evaluation of the concentra-
tion and S/N ratio patterns of the QCBs, as 
well as having homogeneous matrix-based QC 
materials at the relevant concentrations (e.g., 
general population median), were instrumen-
tal in identi fying the contamination of BPA 
from the deionized water.
Contamination of experimental appa-
ratus. The experimental apparatus (e.g., 
septum-equipped test tubes) could be a con-
tamination source when measuring PBDEs 
(Sjödin et al. 2004). Similarly, because BPA 
can leach from plastic [National Toxicology 
Program (NTP) 2008], contamination of 
BPA from plasticware is also possible. On 
one occasion, while analyzing breast milk for 
BPA by on-line SPE-HPLC-MS/MS (Ye et al. 
2008), we observed not only a high S/N ratio 
(S/N = 18.6) of the QCB signal, but also that 
its calculated BPA concentration was consis-
tently 1–2 µg/L above the LOD of 0.3 µg/L 
(Figure 3A). These combined results indicated 
that the contamination of BPA was not sys-
tematic (i.e., at least not in the standards). 
The sample pretreatment included precipita-
tion of milk proteins by methanol, followed 
by centrifugation of the milk in a disposable 
microcentrifuge plastic tube. We added the 
same solvents to standards, QCBs, and milk 
samples, but prepared the solvent-based stan-
dards directly in silanized auto sampler glass 
vials without the centrifugation step. We con-
firmed that the BPA contamination in the 
QCBs came from the leaching of BPA from 
a specific lot of microcentrifuge tubes, even 
though the tubes were presented as made of 
polypropylene, which is not known to con-
tain BPA. When we prepared the QCBs in 
silanized glass autosampler vials, the BPA con-
tamination dissapeared (Figure 3B). To avoid 
future contamination, we modified our proce-
dure and prepared the milk samples in conical 
silanized glass vials instead of plastic micro-
centrifuge tubes; we also reduced the spin 
speed to avoid breaking the glass vials during 
Figure 1. HPLC-MS/MS–extracted ion chromatograms of BPA (m/z ion transition 227/133) of QCBs using a method for the analysis of urine. (A) QCB with BPA 
interference in the water used in the SPE and HPLC mobile phases (QCB signal is equivalent to a concentration of 1.5 µg/L); (B) QCB without BPA interference; 
(C) QCB with BPA interference in the mobile phase, but adding guard cartridges after SPE and HPLC pumps.
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centrifugation. Our findings above reiterate 
the importance not only of including QCBs 
in each analytical batch, but that the QCBs 
have to go through the exact same processing 
protocols, including using the same apparatus, 
as the study samples.
Contamination in the laboratory environ-
ment. Indoor air is a known source of PCBs, 
particularly the low molecular weight congeners 
(Alcock et al. 1994). Similarly, because BPA, 
triclosan, and parabens have been detected in 
indoor dust (Fan et al. 2010; Geens et al. 2009; 
Liao et al. 2012), contamination with these 
ubiquitous chemicals could also come from the 
laboratory environment. In another situation, 
we measured the concentrations of free and 
total (free + conjugated) BPA in serum as part 
of an exposure study. We followed strict QC 
protocols, namely having at least two QCBs, 
two low-concentration QCs, and two high-
concentration QCs in each analytical batch 
with 50 study samples, and including replicate 
analysis of at least 10% of study samples. Even 
with these cautionary measures, we observed 
random contamination of BPA in about 2% of 
the replicate analyses (Teeguarden et al. 2011). 
We first ruled out the potential contamination 
with BPA from solvents and reagents. Because 
BPA can be used in the manufacture of certain 
plastics (NTP 2008) and can be present in 
paper products (Geens et al. 2012; Liao and 
Kannan 2011), we systematically evaluated the 
experimental apparatus used and the materials 
present in our laboratory. We identified the 
absorbent underpad used to cover the work-
space in the laboratory benches as the source of 
the contamination. We specu late that the ran-
dom contamination originated when underpad 
fibers got into the auto sampler vials during 
preparation of the serum for analysis. We elim-
inated this contamination after we replaced the 
absorbent underpad with other bench top pro-
tection sheets that did not contain BPA.
In a similar situation, we detected ran-
dom contamination of triclosan in the QCBs 
and QCs while analyzing urine (Ye et al. 
2005). After ruling out contamination from 
reagents, solvents, and experimental apparatus, 
we discovered that shortly before we noticed 
the contamination, the hand soap in the rest-
rooms dispensers had been replaced with hand 
soap containing triclosan, a broad-spectrum 
antimicrobial agent widely used in soaps in the 
U.S. market (Perencevich et al. 2001). Despite 
using proper personal protection equipment 
for sample preparation in the laboratory, 
including changing gloves often as needed 
during sample preparation, the analysts, after 
washing their hands with the antibacterial 
soap, randomly contaminated some of the 
samples. The triclosan contamination disap-
peared after replacing triclosan- containing 
hand soap in the restroom dispensers with 
triclosan-free soap.
These findings confirm that the general 
laboratory environment and its immediate 
surroundings can also be a potential contami-
na tion source. Noteworthy, because of its ran-
dom pattern, this contamination is usually 
difficult to identify and track down even by 
experienced researchers adhering to a com-
prehensive QC protocol. One approach for 
identifying the potential contamination from 
laboratory environment involves running rep-
licate analysis, particularly when the number 
of study samples is small. If replicate analysis 
is not possible (e.g, limited sample volume), 
another alternative is including additional 
QCBs and QCs within the analytical batch.
The analyst can also be the contamination 
source, especially for chemicals present in 
consumer or personal care products. In another 
example, we noticed random, yet often repeated 
contamination with triclosan in some QCBs 
and QCs included in the batches prepared by 
one analyst, but not others. After ruling out 
the potential contamination sources discussed 
above and confirming that this person followed 
the required standard operating procedures, we 
inventoried all of the situations, both in and 
outside the workplace, where the analyst could 
come in contact with triclosan-containing 
products (Department of Health and Human 
Services 2007; Perencevich et al. 2001). At 
the end of an investigation that took several 
weeks, we determined that the contamination 
started after the analyst changed the toothpaste 
at home to one that contained triclosan. In 
another instance, we encountered a similar 
random contamination with benzo phenone-3 
and parabens. In this case, the contamination 
sources were the analyst’s sunscreen lotion 
and underarm deodorant which contained 
benzophenone-3 and parabens (Department 
of Health and Human Services 2007). In both 
cases, we realized the occurence of contami-
na tion through the abnormal results of the 
QCBs and QCs. After we identified the 
sources of contamination, and although the 
analysts did not have to change their habits 
related to personal care products use, we 
managed to reduce the potential contamina-
tion to negligible levels by conducting all 
sample prepara tion procedures in a biological 
safety cabinet.
Conclusions
Unintended contamination with ubiqui-
tous environmental chemicals, such as BPA 
and other organic compounds (e.g., benzo-
phenone-3, triclosan, parabens), during 
biomonitoring analyses is possible, even with 
state-of-the-art analytical methods and labora-
tory facilities. Unfortunately, until all of the 
environmental sources of these chemicals are 
known, totally eliminating external contam-
ination is practically impossible. However, 
judicious application of the measures below 
Figure 2. On-line SPE-HPLC-MS/MS configuration, adapted from a previous publication (Ye et al. 2008), 
with guard cartridges after SPE and HPLC pumps. The 10-port switching valve configuration shown cor-
responds to the time period when the sample is loaded onto the SPE cartridge.
Figure 3. HPLC-MS/MS extracted ion chromatograms of BPA (m/z ion transition 227/133) of QCBs using a 
method for the analysis of milk. (A) QCB prepared in a plastic microcentrifuge tube; (B) QCB prepared in 
conical silanized glass autosampler vials.
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will allow the identification of contamination 
scenarios, thus facilitating the implementation 
of measures to isolate and track external con-
tamination and minimize as much as possible 
its recurrence and impact.
Evaluate the QCB (i.e., reagent blank) by •	
checking both the calculated concentra-
tion and the S/N ratio of the QCB peak 
to assess any systematic or non-systematic 
contamination.
Prepare the QCBs using the same procedure •	
and apparatus as the unknown study sam-
ples to avoid missing labware and apparatus 
potential contamination.
Use guard columns to filter out potential •	
interference contaminants from the SPE 
mobile phases or separate the chromato grahic 
peak of the target analyte in the study sam-
ples from its interference peak in the HPLC 
mobile phases.
Conduct replicate analyses (e.g., 5%) of •	
study samples to identify random contami-
nation from the laboratory environment 
and/or analyst, especially when the num-
ber of study samples is small. When limited 
sample volume precludes replicate analyses, 
include additional blanks randomly placed 
within the analytical batch.
Prepare the samples for analysis in a con-•	
trolled environment (i.e., biological safety 
cabinet, clean room) if contamination from 
the analyst or the environment (e.g., air, dust) 
is suspected.
Use homogeneous matrix-matched QC mate-•	
rials at concentrations within the expected 
concentration ranges of the study samples.
When possible, participate in external qual-•	
ity assessment programs or use SRMs to 
evaluate the accuracy of the measurement. 
Unfortunately, for nonpersistent environ-
mental organic chemicals (e.g., BPA, benzo-
phenone-3, triclosan, parabens) commercially 
available SRMs do not exist and only BPA is 
routinely included in G-EQUAS. Expanding 
such quality assessment programs and charac-
terizing SRMs to include these chemicals are 
critical to improve the accuracy of biomoni-
toring methods.
In summary, valid biomonotoring data 
require integrating numerous preanalytical and 
analytical steps. First, adequate selection of the 
most relevant biomarkers and biomonotor-
ing matrices as well as collection, handling, 
shipping, and storage procedures to preserve 
the integrity of the specimen and the target 
analytes are needed before starting sample anal-
yses. Second, use of sensitive, selective, and 
accurate analytical methods and state-of-the-
art laboratory facilities. Third, use of highly 
trained laboratory personnel not only to oper-
ate sophisticated instrumentation, but also 
to recognize situations that may compromise 
both the integrity of the biological specimen 
and the validity of its analysis. Last, use of good 
laboratory practices and implementation of 
measures as discussed above to minimize unin-
tended contamination of the biological speci-
mens with the target analytes during analysis. 
We strongly believe that biomonitoring studies 
that maximize the harmonization of the vari-
ous disciplines and expertises (e.g., field inves-
tigation, laboratory analysis) will considerably 
strengthen the exposure assessment.
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